Literature DB >> 7523308

Prevalence of hepatitis C virus infection in the household contacts of patients with HCV-related chronic liver disease.

M Coltorti1, N Caporaso, F Morisco, R Suozzo, M Romano, M D'Antonio.   

Abstract

It is still controversial whether the familial environment plays a role in the diffusion of HCV infection. The aim of this study was to evaluate the prevalence of anti-HCV positivity in the household contacts of patients with HCV-related chronic hepatitis. Nearly all the household contacts of 113 subjects with anti-HCV+ chronic hepatitis (100/113 spouses and 260/290 children) were investigated. Anti-HCV was determined by means of ELISA II and was confirmed by RIBA II. Anti-HCV positivity was found in 27% of the spouses and in 1.9% of the children. Prevalence of anti-HCV positivity in spouses correlated positively with the duration of the marital status. Seventeen/32 (53.1%) of anti-HCV-positive subjects were found to have chronic hepatitis. This study indicates that intrafamilial diffusion of HCV infection is mostly accounted for by horizontal, in particular spouse to spouse, transmission and that spouse to spouse transmission of HCV infection correlates positively with the duration of marital status.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523308     DOI: 10.1007/bf01716699

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  23 in total

1.  Natural horizontal transmission of HCV in microepidemic town in Japan.

Authors:  K Tajima; K Shimotohno; S Oki
Journal:  Lancet       Date:  1991-06-08       Impact factor: 79.321

2.  Intrafamilial transmission of hepatitis C virus.

Authors:  H Kamitsukasa; H Harada; M Yakura; A Fukuda; A Ohbayashi; I Saito; T Miyamura; Q L Choo; M Houghton; G Kuo
Journal:  Lancet       Date:  1989-10-21       Impact factor: 79.321

3.  Antibodies to hepatitis C virus in Italian blood donors.

Authors:  G Sirchia; A Bellobuono; A Giovanetti; M Marconi
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

Review 4.  Polymerase chain reaction for the diagnosis of hepatitis B and C viral hepatitis.

Authors:  C Bréchot
Journal:  J Hepatol       Date:  1993       Impact factor: 25.083

5.  Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection.

Authors:  M J Alter; S C Hadler; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; L A Moyer; H A Fields; D W Bradley
Journal:  JAMA       Date:  1990-11-07       Impact factor: 56.272

6.  Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV.

Authors:  J Tor; J M Llibre; M Carbonell; R Muga; A Ribera; V Soriano; B Clotet; M Sabriá; M Foz
Journal:  BMJ       Date:  1990-11-17

7.  Vertical transmission of hepatitis C virus.

Authors:  M M Thaler; C K Park; D V Landers; D W Wara; M Houghton; G Veereman-Wauters; R L Sweet; J H Han
Journal:  Lancet       Date:  1991-07-06       Impact factor: 79.321

8.  Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Authors:  M E Eyster; H J Alter; L M Aledort; S Quan; A Hatzakis; J J Goedert
Journal:  Ann Intern Med       Date:  1991-11-15       Impact factor: 25.391

9.  Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction.

Authors:  R Novati; V Thiers; A D Monforte; P Maisonneuve; N Principi; M Conti; A Lazzarin; C Brechot
Journal:  J Infect Dis       Date:  1992-04       Impact factor: 5.226

10.  Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C.

Authors:  M W Fried; M Shindo; T L Fong; P C Fox; J H Hoofnagle; A M Di Bisceglie
Journal:  Gastroenterology       Date:  1992-04       Impact factor: 22.682

View more
  1 in total

1.  Hepatitis C virus RNA in serum and liver histology in asymptomatic anti-HCV positive subjects.

Authors:  M Coltorti; M Romano; M Persico; F Morisco; C Tuccillo; N Caporaso
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.